TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-0.74%
↑ 98% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-41.75%
Historical baseline
PeriodValue
2025-0.74%
2024-44.26%
2023-40.25%
2022-37.00%
2021-85.42%
2020-84.61%
20190.00%